Djibouti vs Venezuela: Expected chances of death from non-communicable diseases, by gender
Djibouti
22.1%
in 2021
Venezuela
22.5%
in 2021
Djibouti rank
84th
Venezuela rank
81st
Expected chances of death from non-communicable diseases, by gender over time
- Djibouti
- Venezuela
How they compare
Venezuela currently reports 22.5% against 22.1% in Djibouti, a difference of 0.4%.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Djibouti ahead.
Djibouti ranks 84th and Venezuela ranks 81st of 185 countries.
Djibouti has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Djibouti | Venezuela | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 22.9% | 19.0% | 3.9% | Djibouti |
| 2010s | 22.7% | 20.1% | 2.6% | Djibouti |
| 2020s | 23.0% | 22.6% | 0.4% | Djibouti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher expected chances of death from non-communicable diseases, by gender, Djibouti or Venezuela?
- Venezuela, at 22.5% against 22.1% in Djibouti as of 2021.
- What is the difference in expected chances of death from non-communicable diseases, by gender between Djibouti and Venezuela?
- 0.4%, with Venezuela ahead.
- How many years of comparable data are there for Djibouti and Venezuela?
- 22 years are reported by both, from 2000 to 2021.
- How do Djibouti and Venezuela rank globally for expected chances of death from non-communicable diseases, by gender?
- Djibouti ranks 84th and Venezuela ranks 81st of 185 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Expected chances of death from non-communicable diseases, by gender. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated share of 30-year-olds who would die before their 70th birthday from common non-communicable diseases: any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease.